A blood test could help identify men with advanced prostate cancer most likely to benefit
Audio narration · Coming soon
Research led by The Royal Marsden NHS Foundation Trust and partners suggests a blood test can identify men with advanced prostate cancer who may benefit most from targeted radiotherapy, potentially leading to longer disease control.
Originally published by gnews